IP Library Granted Patent US 7,705,155
Granted Patent B2
US 7,705,155 · App. 11/689,152 · Granted Apr 27, 2010

Processes for the production of useful intermediates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,705,155
App. No.
11/689,152
Granted
Apr 27, 2010
Kind
B2
Abstract

The present application relates to a new process for the asymmetric production of 3-(pyridin-4-yl)-3-hydroxy-pentanoic acid derivatives, which are useful intermediates in the manufacture of compounds that are known to show antiproliferative activity.

Claims (79)

1. A process for the production of compounds of formula (I)

and pharmaceutically acceptable salts and esters thereof, comprising

a) reacting a compound of formula (II),

with a compound of formula (III),

and

b) further reacting in the presence of alkali- or earth alkali metal hydroxides to give the compounds of formula (I),

wherein

R and R 1 are independently, alkyl or benzyl, which benzyl is optionally substituted by one, two or three substituents including —O-alkyl; alkyl or halogen; with the proviso that:

if R is alkyl, R 1 in formula (I) may also be hydrogen or silyl, and R 1 in formula (II) may also be silyl;

R 2 is hydrogen or halogen;

X is

R 3 and R 4 are hydrogen, phenyl, alkyl or

—C(CH 3 ) 2 -phenyl;

R 5 is phenyl, benzyl or alkyl;

R 6 is hydrogen, alkyl or phenyl; and

R 7 is hydrogen, methyl or phenyl; or alternatively

R 5 and R 6 , together with the carbon atoms to which they are attached form an indan moiety and R 7 is hydrogen;

R 11 and R 12 air independently alkyl, cycloalkyl, benzyl or phenyl; and

R 13 is phenyl or alkyl.

2. The process according to claim 1 comprising

a) reacting a compound of formula (II),

with a compound of formula (III),

and

b) further reacting in the presence of alkali- or earth alkali metal hydroxides to give the compounds of formula (I),

wherein

R and R 1 are independently alkyl or benzyl, which benzyl is optionally substituted by one, two or three substituents including —O-alkyl; alkyl or halogen;

R 2 is hydrogen or halogen;

X is

R 3 and R 4 are hydrogen, phenyl, alkyl or —C(CH 3 ) 2 -phenyl;

R 5 is phenyl, benzyl or alkyl;

R 6 is hydrogen, alkyl or phenyl; and

R 7 is hydrogen, methyl or phenyl; or alternatively

R 5 and R 6 , together with the carbon atoms to which they am attached form an indan moiety and R 7 is hydrogen;

R 11 and R 12 are independently alkyl, cycloalkyl, benzyl or phenyl; and

R 13 is phenyl or alkyl.

3. A process according to claim 1 , comprising

a) reacting a compound of formula (II),

with a compound of formula (III),

and

b) further reacting in the presence of alkali- or earth alkali metal hydroxides to give the compound of formula (I),

wherein

R is alkyl; and

R 1 is hydrogen or silyl in formula (I) and silyl in formula (II);

R 2 is hydrogen or halogen:

X is

R 5 is phenyl, benzyl or alkyl;

R 6 is hydrogen, alkyl or phenyl; and

R 7 is hydrogen, methyl or phenyl.

4. The process according to claim 1 or 2 , wherein X is

wherein

R 5 is phenyl, benzyl, isopropyl, tert-butyl or methyl;

R 6 is hydrogen, methyl or phenyl; and

R 7 is hydrogen, methyl or phenyl; or alternatively

R 5 and R 6 together with the carbon atoms to which they are attached, form an indan moiety and

R 7 is hydrogen.

5. The process according to claim 4 , wherein

R 5 and R 6 are both phenyl, and

R 7 is hydrogen.

6. The process according to claim 1 or 2 , wherein the compound of formula (I-1)

is obtained by

a) reacting the compound of formula (II-1)

with the compound formula (III-1)

b) further reacting in the presence of lithium hydroxide in combination with hydrogen peroxide, to give the corresponding compound of formula (I).

7. The process according to claim 1 , wherein the compound of formula (I-2)

is obtained by

a) reacting the compound of formula (II-2)

with the compound of formula (III-2)

b) further reacting in the presence of lithium hydroxide in combination with hydrogen peroxide, to give the corresponding compound of formula (I-2).

8. The process of claim 1 , whereby the process step a) is carried out in the presence of an alkali- or earth-alkali metal amide base.

9. The process of claim 1 , whereby the process step a) is carried out in the presence of lithium hexamethyldisilazane (LHMDS).

10. The process of claim 1 , whereby the process step a) is carried out in a solvent including diethylether (Et 2 O), tetrahydrofuran (THF), tert-butyl methyl ether (TBME), pentane, hexane or heptane.

11. The process according to claim 10 , whereby the solvent of process step a) is tetrahydrofuran (THF).

12. The process of claim 1 , whereby the process step a) is carried out at temperatures between 25° C. and −120° C.

13. The process according to claim 12 , whereby the process step a) is carried out at temperatures between −60° C. and −100° C.

14. The process according to claim 12 , whereby the process step a) is carried out at temperatures between −90° C. and 100° C.

15. The process of claim 1 , whereby the process step b) is carried out in the presence of an alkali- or earth alkali metal hydroxide, alone or in combination with hydrogen peroxide.

16. The process according to claim 15 , whereby the process step b) is carried out in the presence of lithium hydroxide in combination with hydrogen peroxide.

17. The process according to claim 1 or 2 ,

wherein X is

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR NAME PREVIOUSLY RECORDED ON REEL 296336 FRAME 0777. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 5, 2016
From: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S.
To: IPSEN PHARMA S.A.S.
Reel/Frame 037430/0194 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ADDRESS PREVIOUSLY RECORDED ON REEL 023034 FRAME 0251. ASSIGNOR(S) HEREBY CONFIRMS THE ADDRESS SHOULD BE 65 QUAI GEORGES GORSE, 92100 BOULOGNE-BILLANCOURT, FRANCE. Recorded Jan 16, 2013
From: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATION SCIENTIFIQUES (S.C.R.A.S.)
To: IPSEN PHARMA S.A.S.
Reel/Frame 029636/0777 →
CHANGE OF NAME Recorded Jul 31, 2009
From: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATION SCIENTIFIQUES (S.C.R.A.S.)
To: IPSEN PHARMA S.A.S.
Reel/Frame 023034/0251 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2007
From: DIOLEZ, CHRISTIAN; MANGINOT, ERIC; PETERS, RENE; ROLLAND, ALAIN; VEYRAT, MARC
To: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES
Reel/Frame 019106/0241 →